SenzaGen AB
SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also provides biological evaluation, in vitro biocompatibility testing, cytotoxicity, irritation, and skin sensitization medical device services; advisory services for medical devices;… Read more
SenzaGen AB (SENZA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.052x
Based on the latest financial reports, SenzaGen AB (SENZA) has a cash flow conversion efficiency ratio of -0.052x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-3.85 Million) by net assets (Skr74.24 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SenzaGen AB - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how SenzaGen AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
SenzaGen AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SenzaGen AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Forgame Holdings Limited
F:FH0
|
0.001x |
|
Catskill Hudson Bancorp Inc
PINK:CSKL
|
N/A |
|
Etiler İnci Bufe Gida Sanayi ve Dis Ticaret AS
IS:ETILR
|
-0.381x |
|
Interwood-Xylemporia A.T.E.N.E.
AT:XYLEK
|
0.043x |
|
23Andme Holding Co
NASDAQ:ME
|
-0.712x |
|
Cineline India Limited
NSE:CINELINE
|
0.036x |
|
PT Puri Sentul Permai Tbk
JK:KDTN
|
0.045x |
|
Vishwaraj Sugar Industries Limited
NSE:VISHWARAJ
|
-0.120x |
Annual Cash Flow Conversion Efficiency for SenzaGen AB (2014–2024)
The table below shows the annual cash flow conversion efficiency of SenzaGen AB from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr86.64 Million | Skr-9.33 Million | -0.108x | +55.75% |
| 2023-12-31 | Skr67.61 Million | Skr-16.45 Million | -0.243x | -35.83% |
| 2022-12-31 | Skr89.70 Million | Skr-16.07 Million | -0.179x | +5.86% |
| 2021-12-31 | Skr110.24 Million | Skr-20.98 Million | -0.190x | +30.17% |
| 2020-12-31 | Skr107.79 Million | Skr-29.38 Million | -0.273x | -17.68% |
| 2019-12-31 | Skr134.21 Million | Skr-31.08 Million | -0.232x | +14.26% |
| 2018-12-31 | Skr85.94 Million | Skr-23.21 Million | -0.270x | -134.27% |
| 2017-12-31 | Skr101.01 Million | Skr-11.65 Million | -0.115x | +61.09% |
| 2016-12-31 | Skr32.71 Million | Skr-9.69 Million | -0.296x | -96.27% |
| 2015-12-31 | Skr41.61 Million | Skr-6.28 Million | -0.151x | -129.67% |
| 2014-12-31 | Skr2.05 Million | Skr1.04 Million | 0.509x | -- |